KIRKLAND, Wash., Nov. 28, 2018 /PRNewswire/ -- Palo Alto Health Sciences, Inc. (PAHS), the manufacturer of Freespira®,
"I am honored to join Palo Alto Health Sciences at a critical time in their corporate development. As more and more people gain access to Freespira, results consistently show the treatment is a cost-effective long term solution for reducing the symptoms of panic attacks. There is an enormous opportunity to positively impact the quality of life for people suffering from this debilitating condition," said Chris. "We are thrilled to have Chris join the team, and are confident his professional experience, diverse healthcare background, and passion for the mental health field will help us scale quickly," said Debra Reisenthel, Founding CEO of Palo Alto Health Sciences, Inc.
About Palo Alto Health Sciences, Inc. and Freespira®
Palo Alto Health Sciences, Inc. is a privately held digital therapeutic company offering Freespira, an innovative treatment option for people suffering from panic disorder and panic attacks. Freespira is the only FDA-cleared, evidence-based, drug-free solution that is proven to reduce symptoms of panic and panic related disorders after only one month.
www.Freespira.com – (800) 735-8995
View original content:http://www.prnewswire.com/news-releases/palo-alto-health-sciences-names-christopher-s-lento-mba-as-chief-commercial-officer-300756673.html
SOURCE Palo Alto Health Sciences
Subscribe to our Free Newsletters!